About Skymap Pharmaceuticals Private Limited
Data last updated: 30 December 2025
Skymap Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 June 2006, the company has been in operation for over 20 years.
Registered with ROC Delhi under CIN U24233DL2006PTC150088.
Capital: an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹50 Lakh. Formerly known as Skymap Pharma Private Limited and Gsk Pharmaceuticals Private Limited. It is led by directors including Vinod Kumar Gupta and Sanjay Gupta.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 302 Narmada Block – 5 Pocket D – 6 Vasant Kunj, New Delhi, Delhi, India – 110070.
As per the financials filed for FY 2025, the company reported a revenue of ₹409.08 Cr, a growth of 2% compared to the previous year.
The company has a workforce of approximately 314 employees as per the latest available data. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Skymap. As per MCA filings, the company has open charges of ₹415.32 Cr and satisfied charges of ₹292.84 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website skymap.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address302 Narmada Block – 5 Pocket D – 6 Vasant Kunj, New Delhi, Delhi, India – 110070
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited has undergone 2 name changes throughout its history. The company was previously known as Skymap Pharma Private Limited, and Gsk Pharmaceuticals Private Limited.. The current legal name is Skymap Pharmaceuticals Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Skymap Pharmaceuticals Private Limited | Current |
| Skymap Pharma Private Limited | Previous |
| Gsk Pharmaceuticals Private Limited. | Previous |
Associated Brands with Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited operates one associated brand: Skymap. These brands represent Skymap Pharmaceuticals Private Limited's diversified market presence and brand portfolio.
Competitors & Alternatives of Skymap Pharmaceuticals Private Limited
Brands and companies operating in the same space as Skymap Pharmaceuticals Private Limited include Nephron Pharmaceuticals, Suanfarma, Enzene Biosciences and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Nephron Pharmaceuticals
|
Sterile pharmaceutical products are manufactured and contract services are provided. | Florida, Puerto Rico, United States | 1937 |
Suanfarma
|
Generics, nutraceuticals, and APIs are developed by Suanfarma. | Madrid, Spain, Spain | 1993 |
Enzene Biosciences
|
Company specializing in development of Biosimilars | Pune, India, India | 2006 |
Quotient Sciences
|
APIs and finished dosage forms are developed and manufactured. | Nottingham, United Kingdom, United Kingdom | 1990 |
Hybio Pharmaceutical
|
Polypeptide drugs and APIs are developed and manufactured. | Shenzhen, China, China | 1998 |
Aiolos Bio
|
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions | Boston, United States, United States | 2023 |
Kardigan
|
Biotech company developing personalized medicines for cardiovascular diseases | San Francisco, United States, United States | 2023 |
AmbioPharm
|
CDMO and analytical services for peptide development are provided. | North Augusta, United States, United States | 2006 |
Business Activity of Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited is engaged in principal business activities including manufacturing and support service to organizations, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, other support services to organizations. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details for Skymap Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited is audited by Singla Tayal & Co for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Singla Tayal & Co | Locked | Locked | Locked |
Complete auditor history for Skymap Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Vinod Kumar Gupta
Also directs:
Datt Infrastructure And Services Private Limited
|
Director | 12 Oct 2017 | 8 Years 9 Months | Current |
|
Sanjay Gupta
Also directs:
Mks Healthcare Private Limited, Cosmax Pharma Private Limited, Skymap Packaging Private Limited and 5 more
|
Director | 24 Jun 2006 | 20 Years 1 Months | Current |
|
Manish Garg
Also directs:
Cosmax Pharma Private Limited, Glensmith Labs Private Limited, Nortis Lifesciences Private Limited and 1 more
|
Director | 29 Sep 2015 | 10 Years 9 Months | Current |
Financials of Skymap Pharmaceuticals Private Limited FY 2025 filings available
Skymap Pharmaceuticals Private Limited reported revenue of ₹409.08 Cr (up 2.00% YoY) for FY 2025.
Ten-year financial statements for Skymap Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Skymap Pharmaceuticals Private Limited
Shareholding and ownership data for Skymap Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Skymap Pharmaceuticals Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Skymap Lifesciences Private Limited | U24230DL2022PTC408893 | Locked |
| Torrvis Lifesciences Private Limited | U24290DL2023PTC409529 | Locked |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Skymap Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2020 | Hdfc Bank Limited | ₹95 Lakh | Open |
| 02 Aug 2018 | Hdfc Bank Limited | ₹337.09 Cr | Open |
| 02 Jul 2015 | Hdfc Bank Limited | ₹77.29 Cr | Open |
| 23 Jul 2019 | Citi Bank N.A. | ₹8 Cr | Satisfied |
| 26 May 2017 | Hdfc Bank Limited | ₹284.84 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited has a workforce of 314 employees as of Apr 01, 2024.
Employee and EPFO history for Skymap Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Skymap Pharmaceuticals Private Limited
GST registrations and filing compliance for Skymap Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Skymap Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Skymap Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Skymap Pharmaceuticals Private Limited
MSME payment history for Skymap Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Skymap Pharmaceuticals Private Limited
Corporate group structure for Skymap Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Skymap Pharmaceuticals Private Limited
MCA filings and documents for Skymap Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Skymap Pharmaceuticals Private Limited
Frequently Asked Questions about Skymap Pharmaceuticals Private Limited
Skymap Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 24 June 2006 (20+ years old) and is registered under CIN U24233DL2006PTC150088. The company has 314 employees.
Skymap Pharmaceuticals Private Limited reported revenue of ₹409.08 Cr for FY 2025 (up 2.00% YoY).
The current directors of Skymap Pharmaceuticals Private Limited are:
- Vinod Kumar Gupta - Director
- Sanjay Gupta - Director
- Manish Garg - Director
The primary industry of Skymap Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Skymap Pharmaceuticals Private Limited can be reached at the registered office: 302 Narmada Block – 5 Pocket D – 6 Vasant Kunj, New Delhi, Delhi, India – 110070, or through the website skymap.in.
The authorised capital is ₹6.5 Cr, and the paid-up capital is ₹50 Lakh.